Feedback / Questions
ODM-212 - Orion Biotech
https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2026/orion-pharma-announces-the-initiation-of-teades-phase-2-trial-of-odm-212-in-malignant-pleural-mesothelioma-mpm-and-epithelioid-hemangioendothelioma-ehe/
Jan 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next